Medicines usage report (MPA-70MUR)

Under Section 70 of the Medicines and Poisons Act 2019 (MPA), a substance authority is subject to any additional condition decided by the chief executive. Further, section 71 of the MPA requires that a person to whom a substance authority applies must comply with the conditions of the authority unless the person has a reasonable excuse.

Certain substance authorities granted under the Medicines and Poisons (Medicines) Regulation 2021 (MPMR) are subject to the condition that the holder must periodically report medicines usage to the chief executive of Queensland Health (or delegate) — this form must be used for this purpose.


Collection notice

The Department of Health is collecting your information in accordance with Section 70 of the Medicines and Poisons Act 2019 in order to meet reporting requirements for a substance authority holder. Personal information collected by the Department of Health is handled in accordance with the Information Privacy Act 2009. The personal information provided by you may be disclosed to a Hospital and Health Service, Public Health Unit for the purpose of carrying out compliance activity. Your personal information will not be disclosed to other third parties without consent, unless the disclosure is authorised or required by or under law.

For any questions regarding this collection notice, please contact Medicines Approvals and Regulation Unit (MARU) via email: MARU@health.qld.gov.au. For information about how the Department of Health protects your personal information, how to access or correct your own personal information, or how to make a complaint about a breach of the privacy principles and learn how we deal with such a complaint, please refer to: The Department of Health’s Privacy Policy.


Contact information

This notice is managed by the Medicines Approvals and Regulation Unit (MARU). Should you require assistance in completing this form, please email: MARU@health.qld.gov.au.

Required fields are marked with an asterisk (*).
1. Details of person making the notification
2. Details of substance authority holder making the notification
Expiry date *
3. Details of medicines usage
Reporting period beginning
Reporting period ending
Provide details of any medicines held at, or taken to, the site/event/location over the reporting period
Generic name of substance
Quantity
Measure
Form
Strength

Provide details of any medicines used at the site/event/location over the reporting period
Date
Generic name of substance
Qualification
Prescriber's instruction
Further details

4. Additional information and attachments
Certification *
MPA-70MUR, Version 1

Last updated: 1 July 2025